Larix A/S Licenses OmniComm Systems' eClinical Solutions


Larix A/S Licenses OmniComm Systems' eClinical Solutions

FORT LAUDERDALE, Fla., July 2, 2012 (GLOBE NEWSWIRE) – OmniComm Systems, Inc (OTCBB:OMCM), announced that it has signed an agreement with Larix A/S to support their clinical research needs for a 5 year, 31 site study.

Larix, a full-service Clinical Research Organization (CRO) in Denmark offering assistance in all aspects of clinical trials, provides services within statistics, Data Management (DM), Clinical Research (CR), Pharmacovigilance (PV) and Data Monitoring Committees (DMCs) to pharmaceutical, biotechnology and medical device companies. This partnership will enable Larix to provide their customers with high quality products and services to manage complex clinical trials. Larix will utilize OmniComm's fully integrated eClinical suite, including Portal, Electronic Data Capture (EDC), and Clinical Data Management System (CDMS).

"Larix was looking for a system which could support paper, EDC and hybrid studies and which could live up to Larix's quality standards to ensure compliance with regulatory requirements. Furthermore, we wanted a solution that was attractive both from a user's point of view and from a cost point of view. We looked at several solutions but decided in the end to go with OmniComm's eClinical Suite. We believe that the system is flexible and easy to use. We are pleased with this collaboration between Larix and OmniComm." said Klaus Juel Olsen, CEO.

"We are pleased to have been chosen by this prestigious family founded CRO." said Stephen Johnson, President and COO of OmniComm. "They've become one of the largest Danish CROs based on their strong reputation for good customer service, and we look forward to partnering with them to build on their reputation for providing quality solutions and services."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.